Alicesa John
Associate
Asia
Malaysia
Alicesa is a Registered Malaysian Trademark Agent. She graduated with a Bachelor of Laws from the University Technology MARA (UiTM), Malaysia in 2005.
Prior to joining Marks & Clerk (Malaysia), she gained several years of invaluable experience from a well-established IP firm in Malaysia, specifically in relation to Trademarks. Her portfolio involved attending to enquiries, conducting searches, assessing and reporting office actions (including opposition), preparing submissions in response to examiner objections, and other trademark prosecution matters.
Alicesa is fluent in English and Malay.
Languages
- English
- Bahasa Melayu (Malay)
Specialist in
Qualifications
LLB Law, UiTM, 2005
Search our people
Latest Insights
CIPO Update: Patent application delays for filing receipts and application numbers
This article provides an update on the current delays facing patentees in receiving filing receipts and application numbers for patent applications filed in Canada in recent months.
Read more
Finding Innovation and Patents in Neurotech
A neural implant is only one component of a complex system, with potential applications including brain-computer interfacing, medical implant control, prosthetic control, drug delivery, and restoring senses. Whilst current neural implants have matured hugely from the silicon-based Michigan probe developed in the 1980s, significant challenges remain.
Read more
Canada’s New Patent Term Adjustment Framework: Six Things Patentees Need to Know
Canada’s new patent term adjustment (PTA) framework came into force on January 1, 2025.
The PTA framework, which was introduced to satisfy commitments set out in the Canada-United States-Mexico Agreement, is intended to compensate for “unreasonable delays” in patent issuance by providing patentees with an additional term of protection following expiry of the patent’s regular 20-year term.
Read more
The PTA framework, which was introduced to satisfy commitments set out in the Canada-United States-Mexico Agreement, is intended to compensate for “unreasonable delays” in patent issuance by providing patentees with an additional term of protection following expiry of the patent’s regular 20-year term.